Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Clin Transplant ; 25(4): 584-93, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-20633034

RESUMEN

INTRODUCTION: Although cyclosporine A (CSA) is considered to be an efficient immunosuppressive compound in transplantation, vascular side effects like arterial hypertension, neurologic complications and other adverse reactions occur. Interference of CSA with mitochondrial function may be responsible for these side effects. METHODS: We evaluated the effect of CSA on mitochondrial and glycolytic function by measuring fatty acid oxidation (FAO), activities of respiratory chain complexes (RC) and citratesynthase (CS), lactate/pyruvate-ratios, energy-rich phosphates as well as activities of some glycolytic enzymes in human umbilical vein endothelial cells. RESULTS: After 48 h of CSA incubation, global FAO, RC-complexes 1 + 3; 4 and 5 as well as CS were compromised while energy charges were not reduced. Lactate/pyruvate-ratios increased; cellular lactate dehydrogenase (LDH)-, hexokinase- and phosphofructokinase-activities were not impaired by CSA. Moderate cellular toxicity, assessed by LDH leakage, appeared only at the highest CSA concentration. CONCLUSION: Part of CSA toxicity may arise from alterations in mitochondrial function as judged by impaired FAO and respiratory chain enzymes. To some extent, energy balance seems to be maintained by cytosolic energy production. Although only demonstrated for endothelial cells, it is conceivable that such effects will alter energy metabolism of different organs with high oxidative energy demands.


Asunto(s)
Ciclosporina/farmacología , Células Endoteliales de la Vena Umbilical Humana/efectos de los fármacos , Células Endoteliales de la Vena Umbilical Humana/metabolismo , Inmunosupresores/farmacología , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Células Cultivadas , Transporte de Electrón , Metabolismo Energético , Ácidos Grasos/química , Ácidos Grasos/metabolismo , Glucólisis , Humanos , Oxidación-Reducción , Fosforilación Oxidativa
2.
J Perinat Med ; 39(5): 587-93, 2011 09.
Artículo en Inglés | MEDLINE | ID: mdl-21867455

RESUMEN

AIM: The aim of this study was to investigate the impact of gestational age on energy metabolism in human umbilical vein endothelial cells (HUVECs) of preterm and term neonates. METHODS: Activities of respiratory chain (RC) complexes I-V, citrate synthase (CS), overall mitochondrial fatty acid oxidation (FAO), carnitine palmitoyltransferase 2 (CPT2), glycolytic enzymes as well as energy-rich phosphates in HUVECs from uncomplicated term and preterm pregnancies were measured. Neonatal acylcarnitine profiles were analyzed postpartum. RESULTS: Activities of RC complexes II+III, IV, V, and CS were higher in HUVECs from immature pregnancies. Overall FAO did not change, whereas CPT2 activity was higher in term neonates. RC complexes II-V and CS correlated inversely to gestational age, as well as CPT2 activity within the term cohort. Phosphofructokinase activity increased with maturation; lactate dehydrogenase and hexokinase as well as energy-rich phosphates remained constant. In blood, long-chain acylcarnitines were higher in term neonates. CONCLUSIONS: Gestational age-dependent differences of energy-providing pathways in HUVECs were shown. Alterations of RC complexes with gestational age may be an adaptive process to cope with metabolic stress during birth; reduced oxidative phosphorylation and high glycolytic activity make HUVECs less susceptible to peripartum hypoxic damage. We hypothesize that HUVECs of premature neonates are metabolically maladapted to birth, which may be responsible for perinatal complications.


Asunto(s)
Células Endoteliales/metabolismo , Metabolismo Energético , Venas Umbilicales/metabolismo , Carnitina O-Palmitoiltransferasa/metabolismo , Citrato (si)-Sintasa/metabolismo , Estudios de Cohortes , Proteínas del Complejo de Cadena de Transporte de Electrón/metabolismo , Ácidos Grasos/metabolismo , Femenino , Edad Gestacional , Glucólisis , Células Endoteliales de la Vena Umbilical Humana , Humanos , Recién Nacido , Recien Nacido Prematuro , Masculino , Fosforilación Oxidativa , Embarazo , Estudios Prospectivos , Venas Umbilicales/citología
3.
Nutrients ; 13(11)2021 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-34836079

RESUMEN

Sirtuins are nicotinamide adenine dinucleotide (NAD+)-dependent deacetylases that regulate numerous pathways such as mitochondrial energy metabolism in the human body. Lower levels of these enzymes were linked to diseases such as diabetes mellitus and were also described as a result of aging. Sirtuins were previously shown to be under the control of exercise and diet, which are modifiable lifestyle factors. In this study, we analyzed SIRT1, SIRT3 and SIRT5 in blood from a subset of healthy elderly participants who took part in a 12-week randomized, controlled trial during which they performed, twice-weekly, resistance and aerobic training only (EX), the exercise routine combined with dietary counseling in accordance with the guidelines of the German Nutrition Society (EXDC), the exercise routine combined with intake of 2 g/day oil from Calanus finmarchicus (EXCO), or received no treatment and served as the control group (CON). In all study groups performing exercise, a significant increase in activities of SIRT1 (EX: +0.15 U/mg (+0.56/-[-0.16]), EXDC: +0.25 U/mg (+0.52/-0.06), EXCO: +0.40 U/mg (+0.88/-[-0.12])) and SIRT3 (EX: +0.80 U/mg (+3.18/-0.05), EXDC: 0.95 U/mg (+3.88/-0.55), EXCO: 1.60 U/mg (+2.85/-0.70)) was detected. Group comparisons revealed that differences in SIRT1 activity in EXCO and EXDC differed significantly from CON (CON vs. EXCO, p = 0.003; CON vs. EXDC, p = 0.010). For SIRT3, increases in all three intervention groups were significantly different from CON (CON vs. EX, p = 0.007; CON vs. EXDC, p < 0.001, CON vs. EXCO, p = 0.004). In contrast, differences in SIRT5-activities were less pronounced. Altogether, the analyses showed that the activity of SIRT1 and SIRT3 increased in response to the exercise intervention and that this increase may potentially be enhanced by additional dietary modifications.


Asunto(s)
Ejercicio en Circuitos , Dieta/estadística & datos numéricos , Ingestión de Alimentos/fisiología , Sobrepeso/sangre , Sirtuinas/sangre , Anciano , Dieta/efectos adversos , Femenino , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Sobrepeso/terapia , Sirtuina 1/sangre , Sirtuina 3/sangre
4.
Ann Transplant ; 16(2): 68-75, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21716189

RESUMEN

BACKGROUND: Tacrolimus has a wide spectrum of adverse effects, including neurotoxic and vascular events. Vascular dysfunction due to interference of tacrolimus with mitochondrial function in endothelial cells may contribute to these adverse reactions. MATERIAL/METHODS: We evaluated the impact of clinically relevant tacrolimus concentrations after 48 hours on energy metabolism in cultured human umbilical vein endothelial cells (HUVEC): Global fatty acid oxidation (FAO), activities of respiratory chain complexes I-V (RC), citratesynthase (CS), glycolytic enzymes and energy rich phosphates were measured. RESULTS: RC-complexes II+III were significantly compromised at 100 nmol/L and CS at 10, 25 and 50 nmol/L, while global FAO was not significantly impaired. Cellular lactate-dehydrogenase (LDH)-, hexokinase- and phosphofructokinase-activities were not altered; AMP levels increased after 48 hours at 200 nmol/L while energy charges remained stable. No cellular toxicity, assessed by light microscopy and LDH leakage was observed even at highest tacrolimus concentrations. CONCLUSIONS: Tacrolimus partially impaired mitochondrial function in HUVEC at the level of RC-complexes II+III and CS. Part of tacrolimus toxicity and vascular dysfunction may arise from these metabolic alterations. To some extent, energy balance could be maintained by FAO and cytosolic energy production; energy consumption might be economized. Although only demonstrated for endothelial cells, it is conceivable that such effects will alter energy metabolism in different tissues with high oxidative demands.


Asunto(s)
Células Endoteliales/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Inmunosupresores/farmacología , Tacrolimus/farmacología , Venas Umbilicales/efectos de los fármacos , Células Cultivadas , Transporte de Electrón/efectos de los fármacos , Células Endoteliales/citología , Células Endoteliales/metabolismo , Humanos , Mitocondrias/efectos de los fármacos , Mitocondrias/metabolismo , Oxidación-Reducción/efectos de los fármacos , Venas Umbilicales/citología , Venas Umbilicales/metabolismo
5.
Reprod Sci ; 17(3): 219-26, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20065299

RESUMEN

Preeclampsia (PE) and hemolysis, elevated liver enzymes, and low platelet count (HELLP) syndrome have been linked to congenital fetal disorders of mitochondrial fatty acid oxidation (FAO). Different incidences may argue for the association of noncongenital alterations of mitochondrial energy metabolism with PE/HELLP syndrome. We studied human umbilical vein endothelial cells [HUVEC] as selected part of the feto-placental unit from uncomplicated (n = 46) and diseased (n = 27; 17 PE and 10 HELLP) pregnancies by measuring the overall FAO, carnitine palmitoyltransferase 2 (CPT2), respiratory chain (RC) complexes I-V, citratesynthase (CS), lactatedehydrogenase (LDH), hexokinase (HK), phosphofructokinase (PFK), and energy rich phosphates. Maternal and infantile acylcarnitines in blood were investigated post partum. Overall FAO, RC complexes II-V, and CS were significantly compromised in HUVEC from complicated pregnancies; impairment of complexes I + III was not significant. CPT2 and energy charges were unaffected. Lactatedehydrogenase and PFK from complicated pregnancies were upregulated, and HK remained constant. In blood, carnitine was elevated in diseased women and their children, acylcarnitines were higher in affected infants. Impaired mitochondrial function in HUVEC is associated with PE/HELLP syndrome and may be involved in the pathophysiology of these diseases.


Asunto(s)
Células Endoteliales/metabolismo , Síndrome HELLP/metabolismo , Mitocondrias/metabolismo , Enfermedades Mitocondriales/metabolismo , Preeclampsia/metabolismo , Venas Umbilicales , Adulto , Carnitina/análogos & derivados , Carnitina/sangre , Carnitina O-Palmitoiltransferasa/metabolismo , Citrato (si)-Sintasa/metabolismo , Transporte de Electrón , Células Endoteliales/enzimología , Células Endoteliales/ultraestructura , Metabolismo Energético , Ácidos Grasos/metabolismo , Femenino , Glucólisis , Síndrome HELLP/etiología , Humanos , Recién Nacido , L-Lactato Deshidrogenasa/metabolismo , Mitocondrias/enzimología , Enfermedades Mitocondriales/complicaciones , Enfermedades Mitocondriales/enzimología , Complejos Multienzimáticos/metabolismo , Oxidación-Reducción , Fosfofructoquinasas/metabolismo , Preeclampsia/etiología , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA